Association between Hemoglobin Levels in the First 3 Days of Life and Bronchopulmonary Dysplasia in Preterm Infants

Abstract

Objective The objective of this study was to determine the association between hemoglobin (Hb) levels in the first 3 days of life and bronchopulmonary dysplasia (BPD) in preterm infants.

Study Design The study population comprises 147 neonates with a gestational age (GA) of less than 32 weeks who were admitted to BaYi Children's Hospital Affiliated to Beijing Military General Hospital from January 2014 to May 2015. Hb levels in the first 3 days of life, maternal and infant characteristics, were recorded and then analyzed.

Results BPD patients had a lower GA and birth weight than non-BPD patients. Rates of surfactant use, use of early inhalation hormone, days of mechanical ventilation > 2 weeks, and patent ductus arteriosus in BPD patients were higher and have a significant difference. Number of transfusions was higher in BPD patients. Lower Hb levels in the first 3 days of life were also observed in BPD patients. A cutoff value of Hb levels was determined as 155.5 g/L. Hb ≤ 155 g/L in the first 3 days of life was a significant risk factor for BPD.

Conclusion Our study demonstrated that lower Hb levels in the first 3 days of life may increase the risk of developing BPD in preterm infants.

Keywords

bronchopulmonary dysplasia - hemoglobin levels - preterm infants - transfusion

• References

• 1 Truog WE. Bronchopulmonary dysplasia: another step along the path. J Pediatr 2015; 166 (3) 521-522
• 2 Poindexter BB, Jobe AH. The diagnostic conundrum of bronchopulmonary dysplasia. J Pediatr 2015; 167 (3) 517-518
• 3 Strueby L, Thébaud B. Advances in bronchopulmonary dysplasia. Expert Rev Respir Med 2014; 8 (3) 327-338
• 4 Hentschel J, Berger TM, Tschopp A, Müller M, Adams M, Bucher HU ; Swiss Neonatal Network. Population-based study of bronchopulmonary dysplasia in very low birth weight infants in Switzerland. Eur J Pediatr 2005; 164 (5) 292-297
• 5 Jain D, Bancalari E. Bronchopulmonary dysplasia: clinical perspective. Birth Defects Res A Clin Mol Teratol 2014; 100 (3) 134-144
• 6 Zhang H, Fang J, Su H, Chen M. Risk factors for bronchopulmonary dysplasia in neonates born at ≤ 1500 g (1999-2009). Pediatr Int 2011; 53 (6) 915-920
• 7 Lapcharoensap W, Gage SC, Kan P , et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr 2015; 169 (2) e143676
• 8 Mailaparambil B, Krueger M, Heizmann U, Schlegel K, Heinze J, Heinzmann A. Genetic and epidemiological risk factors in the development of bronchopulmonary dysplasia. Dis Markers 2010; 29 (1) 1-9
• 9 Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Legutko M, Pietrzyk JJ. Genetic risk factors of bronchopulmonary dysplasia. Pediatr Res 2008; 64 (6) 682-688
• 10 Li Y, Cui Y, Wang C, Liu X, Han J. A risk factor analysis on disease severity in 47 premature infants with bronchopulmonary dysplasia. Intractable Rare Dis Res 2015; 4 (2) 82-86
• 11 Wang JS. Anemia, heart failure and exercise training. Int J Cardiol 2013; 168 (2) 1525-1526
• 12 Rangel I, Gonçalves A, de Sousa C , et al. Iron deficiency status irrespective of anemia: a predictor of unfavorable outcome in chronic heart failure patients. Cardiology 2014; 128 (4) 320-326
• 13 Liu Q, Dang AM, Chen BW, Lv NQ, Wang X, Zheng DY. The association of red blood cell distribution width with anemia and inflammation in patients with Takayasu arteritis. Clin Chim Acta 2015; 438: 205-209
• 14 Means Jr RT. Anemia of inflammation: clinical insights from mechanisms. Rinsho Ketsueki 2013; 54 (10) 1596-1602
• 15 Stein BL. The anemia of inflammation. J Clin Rheumatol 2012; 18 (8) 437-442
• 16 Kollert F, Tippelt A, Müller C , et al. Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care 2013; 58 (7) 1204-1212
• 17 Hussain SQ, Ashraf M, Wani JG, Ahmed J. Low hemoglobin level a risk factor for acute lower respiratory tract infections (ALRTI) in children. J Clin Diagn Res 2014; 8 (4) PC01-PC03
• 18 Ramakrishnan K, Borade A. Anemia as a risk factor for childhood asthma. Lung India 2010; 27 (2) 51-53
• 19 Bard H, Fouron JC, Chessex P, Widness JA. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity in infants with bronchopulmonary dysplasia. J Pediatr 1998; 132 (4) 630-634
• 20 Silverberg DS, Mor R, Weu MT, Schwartz D, Schwartz IF, Chernin G. Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med 2014; 14: 24
• 21 Martinez-Rivera C, Portillo K, Muñoz-Ferrer A , et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD 2012; 9 (3) 243-250
• 22 Shander A, Goodnough LT, Javidroozi M , et al. Iron deficiency anemia—bridging the knowledge and practice gap. Transfus Med Rev 2014; 28 (3) 156-166
• 23 Berglund S, Westrup B, Domellöf M. Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants. Pediatrics 2010; 126 (4) e874-e883
• 24 Singh R, Visintainer PF, Frantz III ID , et al. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J Perinatol 2011; 31 (3) 176-182
• 25 Cambonie G, Matecki S, Milési C, Voisin M, Guillaumont S, Picaud JC. Myocardial adaptation to anemia and red blood cell transfusion in premature infants requiring ventilation support in the 1st postnatal week. Neonatology 2007; 92 (3) 174-181
• 26 Sandal G, Oguz SS, Erdeve O, Akar M, Uras N, Dilmen U. Assessment of red blood cell transfusion and transfusion duration on cerebral and mesenteric oxygenation using near-infrared spectroscopy in preterm infants with symptomatic anemia. Transfusion 2014; 54 (4) 1100-1105
• 27 Jeon GW, Sin JB. Risk factors of transfusion in anemia of very low birth weight infants. Yonsei Med J 2013; 54 (2) 366-373
• 28 Von Kohorn I, Ehrenkranz RA. Anemia in the preterm infant: erythropoietin versus erythrocyte transfusion—it's not that simple. Clin Perinatol 2009; 36 (1) 111-123
• 29 Mills RJ, Davies MW. Enteral iron supplementation in preterm and low birth weight infants. Cochrane Database Syst Rev 2012; 3: CD005095
• 30 Cooke RW, Drury JA, Yoxall CW, James C. Blood transfusion and chronic lung disease in preterm infants. Eur J Pediatr 1997; 156 (1) 47-50
• 31 Valieva OA, Strandjord TP, Mayock DE, Juul SE. Effects of transfusions in extremely low birth weight infants: a retrospective study. J Pediatr 2009; 155 (3) 331-37.e1
• 32 Zhang Z, Huang X, Lu H. Association between red blood cell transfusion and bronchopulmonary dysplasia in preterm infants. Sci Rep 2014; 4: 4340
• 33 Collard KJ. Is there a causal relationship between the receipt of blood transfusions and the development of chronic lung disease of prematurity?. Med Hypotheses 2006; 66 (2) 355-364
• 34 Del Vecchio A, Henry E, D'Amato G , et al. Instituting a program to reduce the erythrocyte transfusion rate was accompanied by reductions in the incidence of bronchopulmonary dysplasia, retinopathy of prematurity and necrotizing enterocolitis. J Matern Fetal Neonatal Med 2013; 26 (Suppl. 02) 77-79